نتایج جستجو برای: modified atp iii

تعداد نتایج: 560793  

ژورنال: :مجله دانشگاه علوم پزشکی قم 0
مهدی غلام زاده بائیس mehdi gholamzadeh baeis 1young researchers & elites club, qom branch, islamic azad university, qom, iranباشگاه پژوهشگران جوان و نخبگان، واحد قم، دانشگاه آزاد اسلامی، قم، ایران سیامک محبی siamak mohebi 2department of public health, faculty of health, qom university of medical sciences, qom, iranگروه بهداشت عمومی، دانشکده بهداشت، دانشگاه علوم پزشکی قم، قم، ایران مجتبی میلادی نیا mojtaba miladinia 3chronic diseases research center, faculty of nursing & midwifery, ahvaz jundishapur university of medical sciences, ahvaz, iranمرکز تحقیقات بیماری های مزمن، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی جندی شاپور اهواز، اهواز، ایران محمود پرهام mahmood parham clinical research center, qom university of medical sciences, qom, iranمرکز توسعه تحقیقات بالینی، دانشگاه علوم پزشکی قم، قم، ایران

زمینه و هدف: سندرم متابولیک، مجموعه ای از اختلالات متابولیک است که شیوع آن در کل جهان رو به افزایش است و احتمال بروز دیابت نوع 2 و بیماری های قلبی - عروقی را نیز افزایش می دهد. در مطالعه حاضر وضعیت سندرم متابولیک براساس معیار ncep/atp iii در افراد در معرض خطر دیابت بررسی گردید. روش بررسی: در این مطالعه توصیفی - مقطعی، 514 فرد در معرض خطر دیابت (60-20 ساله) مراجعه کننده به بیمارستان امیرالمؤمنین...

Journal: :Separation and Purification Technology 2022

Membrane technology can minimize spread of viruses in the environment during pandemics, however, its efficiency is highly limited by biofouling. In current study, a composite membrane composed commercial material, poly(vinylidene fluoride) (PVDF), and thermo-responsive attapulgite (t-ATP) was developed. The t-ATP synthesized surface modification (ATP) nanofiber with poly(N-isopropylacrylamide) ...

2002
Karol Watson

The National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) released initial guidelines in 1988 (ATP I), followed by ATP II in 1993 and ATP III in 2001. In ATP I and II, treatment recommendations and goals of therapy for secondary prevention are similar. However, ATP III established a more aggressive approach for both secondary prevention and higher risk primary-prevention pat...

Journal: :Journal of applied physiology 2004
Ramy L Hanna Marc P Kaufman

The responses of group III and IV triceps surae muscle afferents to intra-arterial injection of alpha,beta-methylene ATP (50 microg/kg) was examined in decerebrate cats. We found that this P2X(3) agonist stimulated only three of 18 group III afferents but 7 of 9 group IV afferents (P < 0.004). The three group III afferents stimulated by alpha,beta-methylene ATP conducted impulses below 4 m/s. P...

Journal: :iranian journal of pathology 2012
maryam sotoudeh anvari mohammad ali boroumand mahmood sheikhfathollahi leila pourgholi hamidreza goodarzynejad

background and objectives: the association between metabolic syndrome (mets) and hyperuricemia has been formerly studied mostly in healthy people in western countries. we tried to examine the relationship betweenhyperuricemia and mets in an iranian population undergoing coronary angiography. materials and methods: from march 2008 to september 2008, we studied 465 patients (260 men, 55.9%) unde...

Journal: :Biochimica et Biophysica Acta (BBA) - Bioenergetics 2016

2015
Kyung-Sun Han Doo-Yeoun Cho Young-Sang Kim Kyu-Nam Kim

BACKGROUND Limited data exist on the association of serum gamma-glutamyl transferase (GGT) level within the reference range with the increased risk of coronary heart disease (CHD) prediction in men. The study examined the association between serum GGT concentration within the reference range and the CHD risk prediction in Korean men. METHODS The study employed data from Korean National Health...

Journal: :The Journal of biological chemistry 2001
H Habelhah K Shah L Huang A L Burlingame K M Shokat Z Ronai

Modification of the ATP pocket on protein kinases allows selective use of an ATP analogue that exhibits high affinity for the altered kinases. Using this approach, we altered the ATP-binding site on JNK and identified N(6)-(2-phenythyl)-ATP, a modified form of ATP that exhibits high specificity and affinity for the modified, but not the wild type form, of JNK. Using modified JNK and its ATP ana...

2013
Sirijit Suttajit Sutrak Pilakanta

PURPOSE To identify the point prevalence of metabolic syndrome in patients with schizophrenia and to evaluate the association between depressive symptoms and metabolic syndrome in patients with schizophrenia. PATIENTS AND METHODS Metabolic syndrome was assessed based on an updated definition derived from the modified National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP I...

2015
Rayees Ahmad Wani Mansoor Ahmad Dar Rajesh Kumar Chandel Yasir Hassan Rather Inaamul Haq Arshad Hussain Altaf Ahmad Malla

BACKGROUND Patients with schizophrenia suffer high rates of metabolic derangements on some antipsychotic medications that predispose them to cardiovascular diseases. Keeping this fact in mind, we planned this open-label study to see the effect on various metabolic parameters after switching stable schizophrenia subjects, who had developed metabolic syndrome on olanzapine, to aripiprazole. MET...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید